Genenric drug prescribing: Pilot study on the impact of the new drug pricing system on costs and potential savings;Prescription de médicaments génériques: Impact du nouveau système de prix sur les coûts et les économies potentielles

Revue Medicale Suisse

Volumn 2, Issue 59, 2006, Pages 865-871

  Wasserfallen, Jean Blaise ^a   Shimia, Shahram ^a   Biollaz, Jérôme ^a   Pannatier, André ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

DRUG COST; DRUG DELIVERY SYSTEM; DRUG SUBSTITUTION; HUMAN; PILOT STUDY; PRESCRIPTION; REVIEW; UNIVERSITY HOSPITAL; ARTICLE; COST; ECONOMICS; SWITZERLAND;

COSTS AND COST ANALYSIS; DRUGS, GENERIC; HUMANS; PILOT PROJECTS; SWITZERLAND;

EID: 33748070518     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Le marché suisse des médicaments; édition 2005. Interpharma, Basel, 2005. http://www.interpharma.ch (Accès 28 décembre 2005).
2. Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. J Am Pharm Assoc 2000;40:378-83.
3. Valles JA, Barreiro M, Cereza G, et al. A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice. Health Policy 2003;65:269-75.
4. Banahan BF, Kolassa EM. A physician survey on generic drugs and substitution of critical dose medications. Arch Intern Med 1997;157:2080-8.
5. * Mott DA, Cline RR. Exploring generic drug use behaviour. The role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care 2002;40:662-74.
6. Suh DC. Trends of generic substitution in community pharmacies. Pharm World Sci 1999;21:260-5.
7. Anatomical Therapeutical Chemical (ATC) classification index. World Health Organization (WHO), Collaborating Centre for Drug Statistics Methodology, Geneva, 2002. http://www.who.int/medicines/organization/ par/edl/atc-eml-12th- list.doc (Accès 28 dewreath productcembre 2005).
8. Compendium suisse des médicaments. Morant J, Ruppanner H, eds. 21st Edition, Documed, Basel, 2000.
9. Compendium suisse des médicaments. Morant J, Ruppanner H, eds. 23rd Edition, Documed, Basel, 2002.
10. Abdool Karim SS, Pillai G, Ziqubu-Page TT, Cassimjee MH, Morar MS. Potential swings from generic prescribing and generic substitution in South Africa. Health Policy Planning 1996;11:198-205.
11. Tilson L, McGowan B, Ryan M, Barry M. Generic drug utilisation on the General Medical Services (GMS) Scheme in 2001. Ir Med J 2003;96:176-9.
12. * Fischer MA, Avorn J. Economic consequences of underuse of generic drugs: Evidence from Medicaid and implications for prescription drug benefit plans. Health Serv Res 2003;38:1051-63.
13. Haas JS, Phillips KA, Gerstenberger EP, Seger AC. Potential savings from substituting generic drugs for brand-name drugs: Medical Expenditure Panel Survey 1997-2000. Ann Intern Med 2005;142:891-7.